Lieping Chen MD, PhD
United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology); Director, Cancer Immunology Program at Yale Cancer Center
Departments & Organizations
Biological and Biomedical Sciences (BBS): Immunology
Cancer Immunology - Leadership
Immunobiology: Human and Translational Immunology | Chen Lab
Dermatology
Research Interests
Co-signaling molecules, costimulation, coinhibition, modulation of immune responses, molecular mechanisms of lymphocyte activation and deactivation more...
Education
- M.D., Fujian Medical College, 1982
- M.S., Beijing Union Medical College, Beijing, China, 1986
- Ph.D., Drexel University, 1989
Selected Publications
- Sznol M, Chen L. Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin Cancer Res. 19:1021-34, 2013
- Yao S, Zhu Y, Chen L. Advances in targeting cell surface signalling molecules for immune modulation. Nat Rev Drug Discov. 12:130-46, 2013
- Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 13:227-42, 2013
